Now I have all the information I need. Let me synthesize the final review.

---

## Summary

This paper introduces HypoGeneAgent, a framework that uses an LLM (GPT-o3) as a gene-set analyst to generate GO annotations for single-cell clusters across a grid of clustering resolutions, and then selects the optimal resolution by maximizing a Resolution Score that balances intra-cluster annotation agreement (ICS) and inter-cluster annotation distinctiveness (ICD). The method is applied to a K562 Perturb-seq dataset at both gene-expression and perturbation levels. Stage 1 benchmarks annotation quality of multiple LLMs and prompt designs on curated GOBP gene sets; Stage 2 applies the fixed best configuration to resolution selection and compares against silhouette, modularity, and functional enrichment baselines.

## Strengths

- **Novel coupling of LLM annotation with resolution selection**: The idea of using LLM-generated GO annotations to drive a quantitative, biology-aware resolution criterion is genuinely original. No prior work feeds functional feedback back into the clustering hyperparameter choice. The Resolution Score (ICS + ICD) is formally defined and well-motivated (Section 3.4, Table 1).

- **Systematic Stage 1 benchmarking**: The ablation of embedding methods (OpenAI, SapBERT, Nomic AI), prompt designs (general V1/V2, hypothesis), temperature settings, thinking vs. non-thinking LLMs (GPT-4o, GPT-o3, GPT-5, Gemini variants), and top-K candidate ranking (Figures S1–S3) constitutes a thorough characterization of the annotation pipeline before deployment. The finding that GPT-o3 with the hypothesis prompt yields the best and most stable annotations is supported by multiple complementary metrics including AUC and confidence-score calibration.

- **Dual-level application on the same dataset**: The framework is independently applied to GEX-level clusters (using overexpressed gene signatures) and perturbation-level clusters (using perturbed gene lists), with consistent methodology and interpretable results at both levels (Figures 3 and 4). The sensitivity analysis of weight parameter w (Figure S5) provides useful transparency.

- **Clear problem framing and motivation**: The introduction effectively articulates why classical metrics (silhouette, modularity) are biologically agnostic and why resolution selection remains subjective in practice. The paper positions itself well within the growing literature on LLM agents for scientific discovery.

## Weaknesses

### Fatal

None.

### Major

- **No external ground-truth validation of the selected resolution**: The central claim is that the Resolution Score selects biologically superior clustering granularities compared to silhouette and modularity. However, the only validation is that applying the same ICS/ICD/RS framework to traditional GO enrichment results yields a consistent resolution choice (Section 4.4.3, Figure 6). This is partially independent — enrichment uses Fisher's exact test, not the LLM — but it does not constitute a quantitative benchmark against an external criterion. The Perturb-seq data from Replogle et al. includes known perturbation targets that could serve as ground-truth labels (e.g., NMI or ARI against known functional modules), but this is not used. The claim that the method "exceeds traditional metrics" (Section 4.4 summary) is therefore not adequately supported. The comparison in Figures 5a–c only shows that different metrics peak at different resolutions — no external reference determines which peak is correct.

- **Moderate LLM annotation accuracy with no sensitivity analysis**: The Stage 1 benchmark shows a median cosine similarity of ~0.4–0.5 between LLM-generated annotations and curated GO terms (Figure S1d–e). While this is the best among tested configurations, the entire Resolution Score depends on the semantic similarity structure of these moderately accurate annotations. No analysis is provided on how annotation error propagates into ICS/ICD/RS estimates, whether the resolution optimum is stable under annotation perturbation, or how sensitive results are to the choice of embedding model and number of top hypotheses. The claim that GPT-o3 annotations are trustworthy enough to drive parameter selection requires more evidence.

- **Perturbation-level clustering methodology is opaque**: The paper states "for each perturbation level cluster, we can extract the perturbed gene labels list as the input" (line 254) but never specifies how perturbation-level clusters are formed. Are cells grouped by the identity of the perturbed gene? By expression pattern similarity after perturbation? By the target gene module? How the gene-to-cluster assignment matrix ($2005 \times 10$) is constructed is unclear. Without this specification, the perturbation-level results (Figure 4) are neither interpretable nor reproducible. This undermines roughly half of the Stage 2 contribution.

- **Weight w tuned on the same single dataset**: The weight $w = 1/3$ was chosen "by a small grid search and found to give a stable ordering of resolutions across data sets" (Section 3.4). Tuning the evaluation metric's hyperparameter on the same data used to select the resolution raises concerns about overfitting. With only one dataset evaluated, there is no evidence that $w = 1/3$ generalizes.

### Minor

- **Single-dataset evaluation limits generality claims**: Despite the abstract claiming "comprehensive validation on large perturbation datasets," only one K562 Perturb-seq dataset is used. The conclusion's claims of general-purpose applicability to "single-cell, perturb-seq and multi-omics analyses" are not supported by the current experimental scope.

- **Agent design details are underspecified**: The evidence retrieval mechanism (which databases, how queries are formed), how confidence scores are calibrated, and the self-verification loop are described only at a high level (Section 3.3). While the core metrics (ICS, ICD, RS) are well-defined, the annotation agent itself — the component that generates the inputs to those metrics — lacks sufficient detail for independent reimplementation.

- **The claim of "orders of magnitude faster than manual curation"** (Section 4.4 summary) compares against a strawman. There is no timing comparison against existing automated annotation tools (e.g., scmap, CellAssign, or even basic GO over-representation analysis). The runtime claim is unsubstantiated.

### Trivial

- The abstract overstates that the Resolution Score "exhibits alignment with known pathway compared to classical metrics" — the evidence for "known pathway" alignment is the GO enrichment consistency, which is not quite the same as validating against known perturbation biology from the Replogle dataset.
- The conclusion's limitation acknowledgment is just one sentence at the very end, while the preceding paragraphs present the approach as fully validated.

## Nice-to-Haves

- Use the known perturbation targets in the Replogle et al. dataset to construct an external benchmark (e.g., NMI/ARI against co-essentiality modules or pathway databases) that compares the LLM-selected resolution against silhouette- and modularity-selected resolutions head-to-head. This would directly address the major validation gap.
- A sensitivity analysis perturbing LLM annotations (random swaps, different embedding models, varying the number of top hypotheses) to assess whether the resolution optimum is robust to annotation noise.
- Fix $w$ a priori or derive it from a separate validation set rather than grid-searching on the evaluation data.
- Evaluate on at least one additional Perturb-seq dataset to support generality claims.
- Specify the perturbation-level clustering procedure in the main text.

## Removed Points

These points are flagged to be removed; treat them with caution.

- *Harsh Critic, Point 1 sub-claim: "This is entirely circular"* — The GO enrichment validation is not entirely circular because it uses Fisher's exact test and the GO database, which are independent of the LLM. However, the validation strength is limited, which is captured in the Major weakness above.

- *Harsh Critic: "Statistical uncertainty across resolutions... should be accompanied by confidence intervals"* — This is a methodological request that goes beyond standard practice in single-cell clustering benchmarks, where single-run evaluation across resolutions is the norm. Moved to Nice-to-Haves implicitly.

- *Harsh Critic: "Discussion of cost and practical feasibility"* — A useful addition but not a weakness of the current work. The paper already acknowledges LLM cost as a limitation in the conclusion.

- *Harsh Critic: Clustering details "deferred to the appendix" makes assessment impossible* — The paper cites a standard Scanpy pipeline. While more detail in the main text would help, this is standard practice for conference submissions. Key gene-signature extraction details are mentioned (log-fold-change ranking) in the main text. Retained only the agent-design underspecification as a Minor weakness.

- *Strength Finder: "Rigorous two-stage experimental validation"* — "Rigorous" is overstated given the Major validation weaknesses. Retained the two-stage structure as a strength without the adjective.

- *Strength Finder: "Efficient and scalable annotation pipeline... orders of magnitude faster"* — This strength conflicts with the verified weakness that the timing comparison is against a strawman (manual curation). Removed; the timing claim is now listed as a Minor weakness.

- *Strength Finder: "Generalizability across clustering levels"* — This is valid but noted as limited to a single dataset, which is captured in the Minor weakness.

- *Harsh Critic: "The conclusion overclaims the generality and robustness of the method"* — This is a tone/presentation issue already captured by the Minor weakness about single-dataset evaluation and the Trivial note about the conclusion.

## Novel Insights

None beyond the paper's own contributions. The reviewers' observations largely concern validation standards and methodological clarity rather than surfacing genuinely new scientific insights about the approach.

## Suggestions

- The most impactful improvement would be to benchmark resolution quality using the known perturbation targets in the Replogle dataset. Map cells to their CRISPR target genes, group targets by known pathways (e.g., from CORUM, Reactome, or STRING), and compute cluster-to-pathway alignment metrics (NMI, ARI) across the resolution sweep. This provides an external reference against which the Resolution Score, silhouette, and modularity can all be quantitatively compared on equal footing.
- Clarify the perturbation-level clustering: are cells clustered by perturbed gene identity, or by expression similarity after perturbation? Specify the procedure explicitly in the main text with at least one sentence.
- Include a simple perturbation analysis: randomly swap 10–20% of LLM annotations and report whether the resolution optimum shifts.

## Score and Decision

**Calibration summary (all retrieved anchors):**

| Anchor | Score | Round | Comparison |
|--------|-------|-------|------------|
| scMPT (nUpM7egYFd) | 3.40 | R1 (low) | Weaker: surface-level investigation, incremental methodology |
| DrugAgent (PQrkWvQSL0) | 2.50 | R1 (low) | Weaker: limited validation, multi-agent system with unclear benefits |
| GenoAgent (v7aeTmfGOu) | 4.00 | R1 (mid) | Weaker: similar LLM+g enomics domain, but thinner experiments and unclear methods |
| ZerOmics (J1xtkJmFY3) | 4.67 | R1 (mid) / R2 | Comparable-ish: novel LLM application to single-cell, but different task |
| PerturbQA/SUMMER (5WEpbilssv) | 4.60 | R2 | Close comparator: LLM for perturbation biology, novel but validation concerns, ACCEPT |
| Gene benchmark (GDDqq0w6rs) | 4.75 | R2 | Benchmark paper, different contribution type |
| Single-cell retrieval (iOltCu4TPS) | 5.00 | R2 | Benchmark paper, different contribution type |
| BioDiscoveryAgent (HAwZGLcye3) | 6.40 | R1 (mid) / R2 | Stronger: thorough multi-dataset validation, clear quantitative improvements |
| MLE-Bench (6s5uXNWGIh) | 8.00 | R1 (high) | Much stronger: comprehensive benchmark with clear metrics |
| Spider 2.0 (XmProj9cPs) | 8.00 | R1 (high) | Much stronger: different domain |

**Round 1 bracket**: 4.5 – 6.0

**Round 2 narrowing**: HypoGeneAgent is closest to PerturbQA/SUMMER (4.60, ACCEPT) in domain, contribution type, and validation level. HypoGeneAgent has a more novel core concept (closing the annotation-resolution loop) and a more systematic Stage 1 benchmarking study than PerturbQA/SUMMER. However, HypoGeneAgent shares similar validation limitations (single dataset for PerturbQA; single dataset here) and unclear methodology for one component. HypoGeneAgent is notably weaker than BioDiscoveryAgent (6.40), which provides clear, quantitative improvements over baselines across 6 datasets with external validation.

The paper sits slightly above PerturbQA/SUMMER (4.60) due to stronger ablation and a more novel conceptual contribution, but well below BioDiscoveryAgent (6.40). The Major weaknesses — no external validation, moderate annotation accuracy without sensitivity analysis, opaque perturbation-level methodology, and weight tuning on the evaluation data — prevent a score above 5.5. However, the genuine novelty and systematic Stage 1 benchmarking prevent a score below 4.5.

**Final score: 5.0** (borderline, leaning toward the lower half of the 4.5–6.0 bracket due to the validation gaps being structural rather than addressable by minor revision).

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>